Tackling AMR: How implementation research
Antimicrobial Resistance (AMR) is an ongoing silent pandemic, exacerbated in part by the ongoing COVID-19 pandemic. The recently published global burden of bacterial AMR published in The Lancet in January 2022, estimates that based on available evidence in 2019, over 4.95 million deaths globally were associated with drug-resistant infections and 1.27 million deaths were directly caused by drug-resistant organisms. While bacterial AMR was found to be a problem in all regions; the global burden of disease estimates show that the highest burden of AMR is in low and middle-income countries, particularly in the Sub-Saharan African region.
This symposium brought together practitioners, researchers, funders and policymakers to provide a platform for open discussion with an overview of AMR in the One Health context, experiences from the field and to identify what more needs to be done, validate or reality check one health priority areas and highlight how these can be addressed and implemented in the field allowing for translation into policy using a bottom-top approach.
Download the symposium programme (PDF 12.5MB)